Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-19-000026
Filing Date
2019-08-06
Accepted
2019-08-06 17:26:49
Documents
109
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 BHC Q2 2019 FORM 10-Q bauschhealthcompaniesi.htm   iXBRL 10-Q 3751989
2 EXHIBIT 31.1 exhibit311q22019.htm EX-31.1 14312
3 EXHIBIT 31.2 exhibit312q22019.htm EX-31.2 14347
4 EXHIBIT 32.1 exhibit321q22019.htm EX-32.1 8619
5 EXHIBIT 32.2 exhibit322q22019.htm EX-32.2 8608
  Complete submission text file 0000885590-19-000026.txt   14722203

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20190630.xsd EX-101.SCH 84710
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20190630_cal.xml EX-101.CAL 136818
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20190630_def.xml EX-101.DEF 426056
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20190630_lab.xml EX-101.LAB 1026402
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20190630_pre.xml EX-101.PRE 622271
11 EXTRACTED XBRL INSTANCE DOCUMENT bauschhealthcompaniesi_htm.xml XML 3059021
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 191003218
SIC: 2834 Pharmaceutical Preparations